PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$864M
This Quarter Return
+14.61%
1 Year Return
+33.7%
3 Year Return
+258.24%
5 Year Return
+878.92%
10 Year Return
–
AUM
$378M
AUM Growth
+$378M
(+9%)
Cap. Flow
+$11M
Cap. Flow
% of AUM
2.9%
Top 10 Holdings %
Top 10 Hldgs %
31.74%
Holding
97
New
18
Increased
35
Reduced
31
Closed
12
Top Buys
| 1 |
Masimo
MASI
|
$8.26M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$5.72M |
| 3 |
Immunic
IMUX
|
$4.83M |
| 4 |
SDC
SmileDirectClub, Inc. Class A Common Stock
SDC
|
$4.21M |
| 5 |
Zymeworks
ZYME
|
$3.96M |
Top Sells
| 1 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$6.79M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$6.37M |
| 3 |
GNMK
GenMark Diagnostics, Inc
GNMK
|
$4.54M |
| 4 |
Madrigal Pharmaceuticals
MDGL
|
$3.77M |
| 5 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
$3.32M |
Sector Composition
| 1 | Healthcare | 92.08% |
| 2 | Technology | 1.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HZNP
1
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $18.4M | 4.87% | 236,954 -24,952 | -10% | -$1.94M |
|
2
Danaher
DHR
$147B
| $14M | 3.71% | 65,008 +15,008 | +30% | +$3.23M |
|
3
Neurocrine Biosciences
NBIX
$13.8B
| $12.7M | 3.37% | 132,544 +11,018 | +9% | +$1.06M |
|
4
Natera
NTRA
$23.1B
| $12.7M | 3.35% | 175,161 +25,028 | +17% | +$1.81M |
|
5
DexCom
DXCM
$29.5B
| $12.2M | 3.23% | 29,569 -2,991 | -9% | -$1.23M |
|
6
Humana
HUM
$36.5B
| $11M | 2.91% | 26,509 -3,491 | -12% | -$1.44M |
|
7
Merck
MRK
$210B
| $10.4M | 2.76% | 125,834 +8 | +0% | +$664 |
|
8
Edwards Lifesciences
EW
$47.8B
| $9.78M | 2.59% | 122,531 +2,531 | +2% | +$202K |
|
|
TPTX
9
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $9.64M | 2.55% | 110,335 +17 | +0% | +$1.49K |
|
10
Charles River Laboratories
CRL
$8.04B
| $9.06M | 2.4% | 40,005 +5 | +0% | +$1.13K |
|
|
AXNX
11
DELISTED
Axonics, Inc. Common Stock
AXNX
| $9.03M | 2.39% | 176,950 -64,959 | -27% | -$3.32M |
|
12
Vericel Corp
VCEL
$1.83B
| $8.35M | 2.21% | 450,400 -24,896 | -5% | -$461K |
|
13
IQVIA
IQV
$32.4B
| $8.28M | 2.19% | 52,508 +5,008 | +11% | +$789K |
|
|
14
Masimo
MASI
$7.59B
| $8.26M | 2.19% | +35,000 | New | +$8.26M |
|
|
SILK
15
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $8.07M | 2.14% | 120,015 +15 | +0% | +$1.01K |
|
|
CTLT
16
DELISTED
CATALENT, INC.
CTLT
| $7.71M | 2.04% | 90,016 -4,984 | -5% | -$427K |
|
17
Insulet
PODD
$23.9B
| $7.69M | 2.04% | 32,503 +15,003 | +86% | +$3.55M |
|
|
18
Immunic
IMUX
$80.9M
| $7.43M | 1.97% | 400,023 +260,023 | +186% | +$4.83M |
|
|
GNMK
19
DELISTED
GenMark Diagnostics, Inc
GNMK
| $6.82M | 1.81% | 480,199 -319,801 | -40% | -$4.54M |
|
20
AbbVie
ABBV
$372B
| $6.57M | 1.74% | 75,008 +8 | +0% | +$701 |
|
21
UnitedHealth
UNH
$281B
| $6.55M | 1.73% | 21,001 -7,499 | -26% | -$2.34M |
|
22
Vertex Pharmaceuticals
VRTX
$100B
| $6.12M | 1.62% | 22,501 +2,501 | +13% | +$681K |
|
|
DRNA
23
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $5.86M | 1.55% | 325,863 +25,058 | +8% | +$451K |
|
|
ITMR
24
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
| $5.74M | 1.52% | 280,700 +50 | +0% | +$1.02K |
|
|
ALXN
25
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $5.72M | 1.52% | +50,000 | New | +$5.72M |
|